Viewing Study NCT02304393


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-01-06 @ 8:09 AM
Study NCT ID: NCT02304393
Status: COMPLETED
Last Update Posted: 2019-12-13
First Post: 2014-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module